Focus Partners Wealth’s Alpha Tau Medical DRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.32M Buy
184,726
+152,461
+473% +$1.38M ﹤0.01% 1294
2026
Q1
$228K Hold
32,265
﹤0.01% 2346
2025
Q4
$160K Buy
+32,265
New +$136K ﹤0.01% 2483

Other funds holding DRTS

Focus Partners Wealth's DRTS Position: Q2 2026 in Review

Focus Partners Wealth increased its Alpha Tau Medical (DRTS) stake by 473% in Q2 2026, buying an estimated $1.38M and bringing the position to 184,726 shares worth $2.32M. The position accounts for ﹤0.01% of the portfolio, ranked #1294.

Focus Partners Wealth first reported a position in DRTS in Q4 2025 and has held it in 3 quarters since. 74 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.

  • Focus Partners Wealth held 184,726 shares of Alpha Tau Medical worth $2.32M as of Q2 2026.
  • Focus Partners Wealth bought 152,461 Alpha Tau Medical shares in Q2 2026, an estimated $1.38M.
  • Alpha Tau Medical made up ﹤0.01% of Focus Partners Wealth's portfolio in Q2 2026, its #1294 holding.
  • Focus Partners Wealth first reported a position in Alpha Tau Medical in Q4 2025 and has held it in 3 quarters since.
  • 74 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.